Join the Alendronate group to help and get support from people like you.
Alendronate News
FDA Approves Binosto, First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
FREIENBACH, Switzerland, March 14, 2012 /PRNewswire/ – EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved Binosto (alendronate sodium)...
FDA Medwatch Alert: Oral Osteoporosis Drugs (bisphosphonates): Drug Safety Communication - Potential Increased Risk of Esophageal Cancer
Includes: Fosamax (alendronate), Actonel (risedronate), Boniva (ibandronate), Atelvia (risedronate delayed release), Didronel (etidronate), and Skelid (tiludronate) ISSUE: FDA notified healthcare...
Further information
Related condition support groups
Osteoporosis, Aseptic Necrosis